April 19, 2017
CTI CEO to Speak at Covington Business Council Luncheon
FOR IMMEDIATE RELEASE [Cincinnati, OH ~ April 19, 2017]
CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization will present at the the Covington Business Council (CBC) Luncheon, taking placeApril 20th. Timothy J. Schroeder, Founder and Chief Executive Officer, will speak about the company's relocation to Covington as part of the topic "Why Covington?".
"I'm honored to speak about why we believe Covington is a great place for business expansion," according to Schroeder. "We're so excited with what the region has to offer our company, and are looking forward to supporting the community and other local businesses."
The CBC's mission is to actively promote and build a positive business environment in Covington, Kentucky, and this luncheon is a way for local business leaders to connect and network. The luncheon was previewed last week on 91.7FM WVXU as a segment of Cincinnati Edition.
Timothy Schroeder, CEO and Founder of CTI, has over 35 years of clinical, academic, and industry experience in global drug and device development programs. CTI, founded in 1999, is a multi-national research firm with associates in North America, Europe, Latin America and Asia-Pacific. The firm has supported more than 100 drug and device approvals, and currently works on behalf of approximately 120 global pharmaceutical and biotechnology companies. Prior to founding CTI, Tim held numerous faculty positions with the University of Cincinnati College of Medicine. He was also the founding Executive Vice President of Clinical Development at SangStat Medical Corporation, which went public in 1995. Tim is currently a board member for over a dozen corporate and non-profit organizations, including Xavier University, which he attended. Tim was named as an EY Entrepreneur of the Year in 2015 and was recognized as Top Leader by the Enquirer Media in 2016.
About CTI Clinical Trial and Consulting Services
CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in Cincinnati, OH, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com